Canada Pension Plan Investment Board
RCKT icon

Canada Pension Plan Investment Board’s Rocket Pharmaceuticals RCKT Stock Holding History

Canada Pension Plan Investment Board’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$200K Sell
58,500
-2,800
-5% -$9.31K ﹤0.01% 1600
2026
Q1 		$219K Sell
61,300
-33,800
-36% -$134K ﹤0.01% 1543
2025
Q4 		$334K Buy
+95,100
New +$326K ﹤0.01% 1473
2020
Q1 		– Sell
-76,900
Closed -$1.75M – 1442
2019
Q4 		$1.75M Buy
+76,900
New +$1.28M ﹤0.01% 896

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Canada Pension Plan Investment Board's RCKT Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its Rocket Pharmaceuticals (RCKT) stake by 4.6% in Q2 2026, selling an estimated $9.31K and leaving 58,500 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #1600.

Canada Pension Plan Investment Board first reported a position in RCKT in Q4 2019 and has held it in 4 quarters since. The position peaked at $1.75M in Q4 2019. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Canada Pension Plan Investment Board held 58,500 shares of Rocket Pharmaceuticals worth $200K as of Q2 2026.
  • Canada Pension Plan Investment Board sold 2,800 Rocket Pharmaceuticals shares in Q2 2026, an estimated $9.31K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1600 holding.
  • Canada Pension Plan Investment Board first reported a position in Rocket Pharmaceuticals in Q4 2019 and has held it in 4 quarters since.
  • Canada Pension Plan Investment Board's Rocket Pharmaceuticals position peaked at $1.75M in Q4 2019.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.